202

202 Publications Verification

Target:

MMP Parasite Bacterial Antibiotic Apoptosis Akt PI3K

Research Areas:

Infection Neurological Disease Inflammation/Immunology Cancer

Doxycycline monohydrate is an orally active highly lipophilic, tissue-permeable MMP inhibitor with broad-spectrum antibacterial activity. Doxycycline monohydrate is also a semi-synthetic antibiotic with chelating properties, which blocks bacterial protein synthesis and inhibits extracellular matrix degradation through interactions with zinc and calcium atoms. Doxycycline monohydrate also inhibits mitochondrial biogenesis, translation, and the expression of respiratory chain proteins. Doxycycline monohydrate induces apoptosis, inhibits autophagy and EMT, downregulates stem cell markers, and activates the PI3K-AKT pathway, thereby effectively inhibiting the viability and proliferation of cancer cells such as breast cancer cells. Doxycycline monohydrate also promotes the survival and self-renewal of embryonic stem cells and neural stem cells, and reduces the frequency of medium changes in culture. Doxycycline monohydrate has been applied in studies related to breast cancer, prostate cancer, bladder cancer, and other cancers .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

70

Bemcentinib

70 Cited Publications

Cat. No.: HY-15150

CAS No.: 1037624-75-1

Purity: 99.92%

Synonyms: R428; BGB324

Target:

TAM Receptor

Research Areas:

Cancer

Bemcentinib (R428) is a selective and orally active Axl inhibitor with an IC₅₀ of 14 nM. Bemcentinib retards cancer cell migration and invasion. Bemcentinib exhibits >100-fold selectivity for Axl versus Abl and 50- and >100-fold selectivity over TAM family kinases Mer and Tyro3, respectively, in cells. Bemcentinib blocks tumor spread and prolongs survival in models of metastatic breast cancer .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

28

Cl-amidine hydrochloride

28 Cited Publications

Cat. No.: HY-100574A

CAS No.: 1373232-26-8

Purity: 99.82%

Target:

Protein Arginine Deiminase Apoptosis MicroRNA

Research Areas:

Inflammation/Immunology Cancer

Cl-amidine hydrochloride is an orally active peptidylarginine deminase (PAD) inhibitor, with IC₅₀ values of 0.8 μM, 6.2 μM and 5.9 μM for PAD1, PAD3, and PAD4, respectively. Cl-amidine hydrochloride induces apoptosis in cancer cells. Cl-amidine hydrochloride induces microRNA (miR)-16 (miRNA-16, microRNA-16) expression and causes cell cycle arrest. Cl-Amidine hydrochloride prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

28

Cl-amidine TFA

28 Cited Publications

Cat. No.: HY-100574B

CAS No.: 1043444-18-3

Target:

Protein Arginine Deiminase Apoptosis MicroRNA

Research Areas:

Inflammation/Immunology Cancer

Cl-amidine TFA is an orally active peptidylarginine deminase (PAD) inhibitor, with IC₅₀ values of 0.8 μM, 6.2 μM and 5.9 μM for PAD1, PAD3, and PAD4, respectively. Cl-amidine TFA induces apoptosis in cancer cells. Cl-amidine TFA induces microRNA (miR)-16 (miRNA-16, microRNA-16) expression and causes cell cycle arrest. Cl-Amidine TFA prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

25

Molibresib besylate

25 Cited Publications

Cat. No.: HY-13032B

CAS No.: 1895049-20-3

Purity: 97.04%

Synonyms: GSK 525762C; I-BET 762 besylate

Target:

Epigenetic Reader Domain ERK

Research Areas:

Cancer

Molibresib besylate (GSK 525762C; I-BET 762 besylate) is an orally active pan-BET inhibitor that targets and binds to BRD2, BRD3, BRD4 and BRDT. By competitively occupying acetylated lysine binding sites, Molibresib besylate disrupts the interaction between BET proteins and chromatin, thereby effectively inhibiting MYC expression and target gene transcription. Molibresib besylate exhibits broad antiproliferative activity, which not only inhibits cancer cell growth and induces growth arrest, but also downregulates mitosis-related genes and upregulates the level of p-ERK1/2. When combined with MEK inhibitors, Molibresib besylate shows a significant synergistic effect, reduces tumor burden in mouse models of leukemia, modulates the immune microenvironment and prolongs survival. Molibresib besylate is widely applicable to research related to acute myeloid leukemia, multiple myeloma, triple-negative breast cancer, small-cell lung cancer and various advanced refractory solid tumors .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

23

Itacitinib

23 Cited Publications

Cat. No.: HY-16997

CAS No.: 1334298-90-6

Synonyms: INCB039110

Target:

JAK STAT

Research Areas:

Inflammation/Immunology Cancer

Itacitinib (INCB039110) is an orally active selective inhibitor of JAK1 with an IC₅₀ value of 2 nM for human JAK1. Itacitinib inhibits IFN-γ-mediated phosphorylation of STAT1 and downstream pro-inflammatory signaling pathways. Itacitinib reduces the frequency and number of splenic neutrophils in mouse models, downregulates the levels of pro-inflammatory cytokines and chemokines, and inhibits pro-inflammatory gene expression pathways. Itacitinib improves survival rate and clinical scores in mouse models of hemophagocytic lymphohistiocytosis (HLH), and also suppresses metastasis in NSCLC models with high Rab1A expression. Itacitinib can be used for research on hemophagocytic lymphohistiocytosis and non-small cell lung cancer .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

23

Itacitinib adipate

23 Cited Publications

Cat. No.: HY-16997A

CAS No.: 1334302-63-4

Synonyms: INCB039110 adipate

Target:

JAK STAT

Research Areas:

Inflammation/Immunology Cancer

Itacitinib adipate (INCB039110 adipate) is an orally active JAK1-selective inhibitor. Itacitinib adipate inhibits IFN-γ-mediated phosphorylation of STAT1 and downstream pro-inflammatory signaling pathways. Itacitinib adipate reduces the frequency and number of splenic neutrophils in mouse models, downregulates the levels of pro-inflammatory cytokines and chemokines, and inhibits pro-inflammatory gene expression pathways. Itacitinib adipate improves survival rate and clinical scores in mouse models of hemophagocytic lymphohistiocytosis (HLH), and also suppresses metastasis in NSCLC models with high Rab1A expression. Itacitinib adipate can be used for research on hemophagocytic lymphohistiocytosis and non-small cell lung cancer .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

11

Onalespib

11 Cited Publications

Cat. No.: HY-14463

CAS No.: 912999-49-6

Purity: 99.92%

Synonyms: AT13387

Target:

HSP

Research Areas:

Cancer

Onalespib (AT13387) is a potent and cross the blood-brain barrier heat-shock-protein-90 (Hsp90) inhibitor. Onalespib inhibits the proliferation, survival and migration. Onalespib decreases the expression of EGFR, p-EGFR, AKT, P-AKT, ERK1/2, P-ERK1/2, S6, P-S6 protein. Onalespib shows antitumor activity. Onalespib has the potential for the research of non-small cell lung cancer (NSCLC) .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

5

SAICAR

5 Cited Publications

Cat. No.: HY-126585

CAS No.: 3031-95-6

Purity: 99.57%

Category:

Human Gut Microbiota Metabolites Microorganisms Ketones, Aldehydes, Acids Disease markers Endocrine diseases Nervous System Disorder Endogenous metabolite Disease Research Fields Cancer

Target:

Endogenous Metabolite

SAICAR is an intermediate of de novo purine nucleotide biosynthesis, activates pyruvate kinase isoform M2 (PKM2) in an isozyme-selective manner, with an EC₅₀ of 0.3 mM. SAICAR stimulates PKM2 and promotes cancer cell survival in glucose-limited conditions .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

4

NNK

4 Cited Publications

Cat. No.: HY-126477

CAS No.: 64091-91-4

Purity: 99.98%

Category:

Alkaloids Pyridine Alkaloids Endogenous metabolite Disease Research Fields Cancer

Target:

Endogenous Metabolite

NNK is a nicotine-nitrosated derivative. NNK simultaneously stimulates Bcl2 phosphorylation exclusively at Ser ⁷⁰ and c-Myc at Thr ⁵⁸ and Ser ⁶² through activation of both ERK1/2 and PKCα . NNK induces survival and proliferation of human lung cancer cells. NNK can be used for lung cancer mice model structure .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

4

Nuvisertib

4 Cited Publications

Cat. No.: HY-101126

CAS No.: 1361951-15-6

Purity: 99.96%

Synonyms: TP-3654

Target:

Pim JAK mTOR c-Myc TGF-β Receptor BCRP

Research Areas:

Cancer

Nuvisertib (TP-3654) is an orally active second-generation pan-PIM kinase inhibitor with K_i values of 5 nM, 239 nM, and 42 nM against PIM-1, PIM-2, and PIM-3, respectively. Nuvisertib inhibits JAK-independent inflammatory and survival signaling pathways, reduces the production of proinflammatory cytokines, restores apoptotic sensitivity, inhibits mTORC1, MYC, and TGF-β signaling pathways, and decreases the expression of fibrosis markers. Nuvisertib selectively impairs the transport function of ABCG2, resensitizes multidrug-resistant cancer cells to cytotoxic drugs, and overcomes JAK2 inhibitor resistance. Nuvisertib can be used in research related to myelofibrosis, renal cell carcinoma, multidrug-resistant cancer, advanced solid tumors, urothelial carcinoma, and prostate adenocarcinoma .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

3

Panitumumab

3 Cited Publications

Cat. No.: HY-P99041

CAS No.: 339177-26-3

Synonyms: ABX-EGF

Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .

Compare

loading...